FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Approves New 300mg Plavix

[ Price : $8.95]

FDA approves a Sanofi-aventis and Bristol-Myers Squibb supplemental NDA for a 300 mg loading dose of its Plavix for acute coronary...

FDA OKs Pfizer sNADA for Bovine Respiratory Disease

[ Price : $8.95]

Federal Register Final rule: FDA approves a Pfizer supplemental NADA that adds a pathogen to the indication for tulathromycin in c...

FDA Approves Akorn Manufacturing Site

[ Price : $8.95]

FDA approves an alternate manufacturing site for Akorns IC-Green.

FDA Mulls Exclusivity Forfeiture on Generic Precose

[ Price : $8.95]

FDA considers invoking forfeiture on 180-day generic drug exclusivity for pending generic applications seeking to market copies of...

FDA Too Weak on Imports, Needs More IT: Ex-agent

[ Price : $8.95]

A former FDA regulatory counsel and special agent says FDA is flying blind on important surveillance and badly needs new funding f...

FDA Judge Insists on $510,000 TMJI Penalty

[ Price : $8.95]

FDAs administrative law judge reasserts $510,000 civil money penalties against TMJ Implants Inc., agreeing with CDRH that the comp...

Express Scripts Subsidiary Settles Suit

[ Price : $8.95]

Specialty Distribution Services pays $10.5 million in a deferred prosecution agreement over illegally distributing human growth ho...

CDRH Wants Device ISO 13485 Audit Reports

[ Price : $8.95]

CDRH Office of Compliance director Tim Ulatowski tells RAPS that his office will soon allow device makers to voluntarily submit IS...

Deaths Reported with Fentora Use

[ Price : $8.95]

FDA warns doctors and pharmacists that improper use of Cephalons Fentora can lead to death and other adverse events.

FDA Extends Deadline on Solvay NDA

[ Price : $8.95]

Additional data prompts FDA to extend the PDUFA deadline for a Solvay Pharmaceuticals NDA for tedisamil for treating recent onset ...